These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6131314)
1. Modified response to ketoconazole of Candida albicans from a treatment failure. Warnock DW; Johnson EM; Richardson MD; Vickers CF Lancet; 1983 Mar; 1(8325):642-3. PubMed ID: 6131314 [No Abstract] [Full Text] [Related]
2. Azole resistance in Candida albicans. Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106 [TBL] [Abstract][Full Text] [Related]
3. Ketoconazole in a case of chronic mucocutaneous candidiasis. Zachariae H; Laurberg G; Thestrup-Pedersen K Acta Derm Venereol; 1982; 62(1):87-9. PubMed ID: 6175153 [TBL] [Abstract][Full Text] [Related]
4. Therapy of chronic mucocutaneous candidiasis. Rosenblatt HM; Stiehm ER Am J Med; 1983 Jan; 74(1B):20-2. PubMed ID: 6295148 [TBL] [Abstract][Full Text] [Related]
5. Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicans. Beggs WH Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):495-8. PubMed ID: 6294764 [TBL] [Abstract][Full Text] [Related]
6. Combined activity of ketoconazole and sulphamethoxazole against Candida albicans. Beggs WH J Antimicrob Chemother; 1982 Dec; 10(6):539-41. PubMed ID: 6298174 [No Abstract] [Full Text] [Related]
7. The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium. Van Cutsem J; Borgers M; De Brabander M Mykosen; 1981 Oct; 24(10):596-602. PubMed ID: 6270550 [No Abstract] [Full Text] [Related]
8. Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363. Lamb DC; Kelly DE; Manning NJ; Kelly SL FEMS Microbiol Lett; 1997 Feb; 147(2):189-93. PubMed ID: 9119192 [TBL] [Abstract][Full Text] [Related]
9. Effect of ketoconazole on the initial stages of germ tube formation by strains of Candida albicans. Johnson EM; Barnard ML; Richardson MD; Warnock DW Mykosen; 1982 Sep; 25(9):481-6. PubMed ID: 6292712 [No Abstract] [Full Text] [Related]
10. Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans. Sud IJ; Feingold DS Antimicrob Agents Chemother; 1983 Jan; 23(1):185-7. PubMed ID: 6299182 [TBL] [Abstract][Full Text] [Related]
11. Effects of pH on the activity of ketoconazole against Candida albicans. Minagawa H; Kitaura K; Nakamizo N Antimicrob Agents Chemother; 1983 Jan; 23(1):105-7. PubMed ID: 6299178 [TBL] [Abstract][Full Text] [Related]
12. Ketoconazole in the treatment of chronic mucocutaneous candidiasis secondary to autoimmune polyendocrinopathy-candidiasis syndrome. Appleboom TM; Flowers FP Cutis; 1982 Jul; 30(1):71-2. PubMed ID: 6288325 [No Abstract] [Full Text] [Related]
14. The activity of ketoconazole in mixed cultures of fungi and human fibroblasts. Aerts F; De Brabander M; van den Bossche H; van Cutsem J; Borgers M Mykosen; 1980 Feb; 23(2):53-67. PubMed ID: 6247651 [No Abstract] [Full Text] [Related]
15. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Horsburgh CR; Kirkpatrick CH Am J Med; 1983 Jan; 74(1B):23-9. PubMed ID: 6295149 [TBL] [Abstract][Full Text] [Related]
16. Chronic mucocutaneous candidiasis with a serum-dependent neutrophil defect: response to ketoconazole. Kennedy CT; Valdimarsson H; Hay RJ J R Soc Med; 1981 Feb; 74(2):158-62. PubMed ID: 6259351 [No Abstract] [Full Text] [Related]
17. The treatment of patients with chronic mucocutaneous candidosis and candida onychomycosis with ketoconazole. Hay RJ; Clayton YM Clin Exp Dermatol; 1982 Mar; 7(2):155-62. PubMed ID: 6282505 [No Abstract] [Full Text] [Related]